Complete Archive

A heart transplant is not a recovery. Recovery implies a baseline to return to, and there isn’t one. The years of decline didn’t pause while the surgery happened—they accumulated, and what they accumulated was loss.

First post-discharge biopsy, and I needed a ride. Mom was sick and knew better than to come near me. Teresa was at Children’s, where my youngest had woken up with what turned out to be appendicitis. Two procedures, two hospitals, one morning, opposite ends of the city.

Nine days post-transplant. Sixty days in the hospital. Then discharge papers, the last lines pulled, and a car pulling away from the building with me inside. The house is a bilevel—steps up from the driveway. Under normal circumstances, unremarkable.

Five days post-transplant, the A-line out, the recovery ICU finally behind me. Up and walking twice daily. No raising your hands above your head—the sternum has been opened and wired back together and it needs time. The people on this ward were closer to leaving. Not all of them would.

The morning after surgery I woke up in terror. Not the disoriented kind—I knew exactly where I was, knew the heart was in, knew everything had gone by the book. My intellect was fully online. And I was terrified anyway.

The nurse came through the door differently. Ten-fifteen on a Thursday evening, the ward settled into its overnight quiet. Sam came in holding a phone, and the way she was moving told you something before she handed it over.

Tom Petty had it right, though not for the reasons most people assume. It isn’t patience—patience is something you can summon. The runway is short, the lift-off isn’t yours to control, and somewhere out there is a stranger whose story you will never fully know.

There’s a transaction that happens the moment you’re admitted for a long stay, and nobody walks you through the terms. Every input measured, every output logged. You don’t eat, move, or clean yourself without it being recorded. This is not cruelty. It’s medicine.

Lines in, lines out. The Impella running its quiet rhythm. The monitor glowing green behind my head. That’s what a support system looks like from the inside—not dramatic, not cinematic. It looks like logistics. It looks like someone already moving before you’ve asked them to.

Listed on a Friday afternoon. Status 2, on an Impella, waiting. Three days of relative stability. Monday nearly killed me. By Thursday I’d walked four laps around the ward and eaten a real lunch and started to feel like a man who might survive long enough to get a heart. Then endocrine walked in.

The nightmare woke me at 1:44 in the morning. I felt the kick first, electrical charge running through my chest and arm and head, and came up out of sleep certain the ICD had fired. The nurses pulled the EKG records to prove it hadn’t.

The Impella went in on October 3rd—a catheter-mounted pump threaded into the left ventricle to do the work the heart no longer could. Five percent ejection fraction going in. What happened in the hours afterward was not, primarily, a clinical experience.

My wife wanted me to go to the hospital sooner. She always did. Twenty-five years of the same standing argument: her instinct to call in the armada, mine to assess and manage. We were both right, and that’s the part that took longest to understand.

Early thirties, recently married, a second child on the way. Slightly short of breath—unusual enough to mention, not unusual enough to worry about. My cardiologist ordered the standard workup to rule things out, then came back into the room, sat down, and said my case had just become a lot more interesting.

Death came to my room more than once. The first time I was at home, alone in the dark, and woke to a figure crouched near the ceiling with the patience of something that had nowhere else to be. I had known for years I would die at fifty-five.

Head to toe, literally. The dermatologist worked scalp to legs with the kind of systematic attention that makes you realize how rarely anyone looks at you that carefully. A skin tag off the back, a biopsy off the arm, and a short list of things to watch for.

Home nine days after the transplant, four days before Thanksgiving, cold and flu season already underway and COVID still the bigger worry of the three. My immune system had just been deliberately suppressed to its lowest point. The timing was not ideal.

Wearables can tell you a remarkable amount about your body. The trick is knowing what they measured, what they inferred, and what they simply guessed. The distance between the sensor and the number on your screen matters more than almost anything else about the device.

Someone asks the group about tea, and before the question is properly answered the same reply turns up: I drink Earl Grey five days a week and I’m fine. That sentence establishes exactly one thing, and it isn’t the thing people think it is.

The dangerous things announce themselves: the amber vial, the childproof cap, the pharmacist’s short speech at the counter. The harder part is the coffee. The comfort tea. The gummy on the nightstand. The sparkling water in the checkout cooler.

There’s an assumption quietly embedded in transplant medicine: the hospital is here, and therefore so are you. Nobody says it out loud. I live fifteen minutes from the building, so distance was never my problem. For a lot of recipients it’s the hardest variable in the entire process.

There’s a grief in transplant circles that doesn’t get named often enough. Not the grief of nearly dying, or the long wait, or the recovery. Quieter than those—the grief of losing the entire system by which you understood health itself.

Nearly every heart transplant recipient meets insulin in the first weeks. The only question is whether you come home on it. That isn’t a prediction about outcomes—it’s pharmacology. The immunosuppression produces a glucose load no oral agent can adequately manage.

Most people have taken prednisone at some point—a five-day dose pack, a short course after a procedure. It works fast, the side effects are manageable, and then it’s done. That experience creates a frame of reference that does not apply after a transplant.

You came home from the hospital with a pill bottle. Twice daily, same times every day, and the instructions are presented as non-negotiable. Where the drug came from, what the trough number actually means, what moves it, and what the real side-effect landscape looks like.

Immunosuppression gets most of the attention, and it should. But it isn’t the only thing in the bag you bring home. A second tier of medications exists because immunosuppression opens specific doors a healthy immune system keeps closed. Each one is standing guard at a particular door.

The transplanted heart is living tissue carrying someone else’s genetic signature, and the immune system was built to treat exactly that as a threat. That isn’t a malfunction. It’s the system doing precisely what it was designed to do.

Every transplant group has the same post, usually around two in the morning: why am I always low on magnesium, and why doesn’t taking more of it fix anything? The answer runs through kidney physiology, drug pharmacology, and the particular frustration of a supplement doing a job the body keeps undoing.

Most people carry two assumptions into a transplant: that anything taken for years without incident is safe to continue, and that “natural” occupies a different category from “drug.” Both are wrong afterward, and the consequences run from destabilized medication levels to rejection.

I texted Eric that morning to say things had taken another downturn and I might not come back from this. He answered the way Eric answers: a bad joke about the Six Million Dollar Man, then something that cut straight through. I went to the OR a few hours later.

The discharge paperwork is thorough the way a legal document is thorough—complete, technically accurate, and practically insufficient. It tells you what to do. It doesn’t tell you why the restrictions exist, how long they apply, or how the calculus changes as recovery progresses.

The diagnosis has landed and the team has already moved. What managing cardiac allograft vasculopathy actually looks like is not a single medication adjustment—it runs across immunosuppression, lipid pharmacology, metabolic management, diet, and surveillance, each piece addressing a different part of the problem.

A year out, the numbers looked the way you hope numbers look. Ejection fraction solid, pressures normal, biopsy clean, bloodwork good across the board. The team was pleased. I was pleased. Then they mentioned something else.

Nobody hands you a shopping list at discharge. They hand you prescriptions, a follow-up schedule, and a set of dietary restrictions. Everything you actually need to manage the day-to-day—the tools, the devices, the supplies—you work out by trial and error, usually after the error.

Someone counted during the initial workup—roughly fifty vials in a single sitting. A full cup of yourself, handed over one vacuum-sealed tube at a time. Then near-daily draws, then twice weekly, then weekly, until both arms carry the geography of a patient under close surveillance.

The discharge packet covers medications, follow-up appointments, dietary restrictions, and warning signs. It does not cover what the next several months are going to feel like: crying without a cause, dread that arrives in the morning attached to nothing, flatness where feeling should be.

A long line from below the neck to the base of the sternum. One where the old pacemaker sat, another where the Impella went in. Marks below the rib cage from the drains, a thin trace at the base of the neck from the thyroid, faint catheterization marks on both wrists.

There’s a clause in the contract of being alive that everyone carries and almost nobody reads. The arrangement is temporary. It will end. The terms are non-negotiable and the timeline is undisclosed. You signed it the moment you arrived, without reading it.

There’s a moment when the psychological weight of a transplant lands fully. For some it’s the listing, for others the wait, or the table, or the long recovery after. For me it came before any of that—the moment I said yes.

Almost every transplant candidate thinks it and almost none of them say it out loud: someone has to die for me to live. It arrives before the testing, before the waitlist, before surgery is anything but an idea. The first crisis is usually moral.

When something happens that I can’t explain, I don’t explain it. I hold it intact, exactly as it arrived, and refuse to file it under a category that would make it smaller and easier to carry. That practice is the only thing that makes the rest of this account trustworthy.

The Egyptians pulled the brain out through the nose with a hook and threw it away. It was packing material. The heart they left exactly where it was, because the heart was where the person lived. They weren’t eccentric in this, and they weren’t alone.

There’s a moment in the recovery arc when you realize the person you’ve been looking for was there the whole time. Not rebuilt. Not reconstructed from parts. Retrieved—the way you find something you misplaced and recognize it instantly.

The voice went in late September 2024, somewhere in the middle of the AFib cascade that brought everything to a head. The assumption at the time was acid damage—the kind of thing that heals on its own in a week or two. There is a version of this story where it’s a footnote.

The heart was beating, the surgery was done, and by every external measure the crisis had passed. What the discharge packet doesn’t cover is that the emotional accounting hasn’t started yet—and that the prednisone exposure began weeks before the transplant did.

The number 55 had been hanging there for years. Not a premonition—a calculation, the kind that runs quietly in the background when you know your body well enough and have been paying attention long enough to see where the line goes. When things fell apart after that birthday, it didn’t surprise me.

More blood moving, more oxygen reaching places that had been running on fumes for years. I hadn’t known how far gone I was until the contrast arrived. Then, lying in the ICU with nothing to do but think, the questions started accumulating.